• Free Shipping on Orders $200+ • 3rd-Party Lab Tested • Backed by Clinical Research • 100% Purity Guarantee • GMP-Certified Labs • Verified Potency & Authenticity
• Free Shipping on Orders $200+ • 3rd-Party Lab Tested • Backed by Clinical Research • 100% Purity Guarantee • GMP-Certified Labs • Verified Potency & Authenticity
• Free Shipping on Orders $200+ • 3rd-Party Lab Tested • Backed by Clinical Research • 100% Purity Guarantee • GMP-Certified Labs • Verified Potency & Authenticity

Top Research Peptides for Fat Metabolism Studies

Fat loss research peptides target multiple metabolic pathways — from appetite regulation and energy expenditure to direct lipolysis and mitochondrial function. This guide covers the most evidence-backed peptides for fat metabolism research in 2026.

1. Semaglutide — The GLP-1 Standard

Semaglutide is the most extensively studied peptide for metabolic research with robust Phase 3 clinical trial data. It reduces appetite through GLP-1 receptor activation, delays gastric emptying, and improves insulin sensitivity. Dosage guide | Full overview

2. Tirzepatide — Dual GLP-1/GIP Agonist

Tirzepatide builds on semaglutide’s foundation by adding GIP receptor activation, enhancing energy expenditure and lipid metabolism. Clinical data shows superior metabolic outcomes vs semaglutide alone. Dosage guide

3. Retatrutide — Triple Agonist

Retatrutide adds glucagon receptor activation to the GLP-1/GIP combination, promoting hepatic fat oxidation and thermogenesis for the most comprehensive metabolic profile. Dosage guide

4. AOD 9604 — Direct Lipolysis

AOD 9604 directly stimulates fat breakdown through beta-3 adrenergic pathways without affecting growth hormone, IGF-1, or blood glucose. Unique for isolated lipolysis research. Dosage guide

5. MOTS-C — Mitochondrial Metabolism

MOTS-C activates AMPK to enhance glucose uptake and fatty acid oxidation. As an exercise mimetic, it targets fat metabolism through mitochondrial pathways. Dosage guide

6. Tesamorelin — Visceral Fat Focus

Tesamorelin is the only FDA-approved GHRH analog, with clinical data showing 15-18% visceral fat reduction. Targets deep abdominal fat specifically. Dosage guide

Comparison Table

Peptide Mechanism Target Administration
Semaglutide GLP-1 agonist Appetite/insulin Weekly SC
Tirzepatide GLP-1/GIP dual Appetite/energy expenditure Weekly SC
Retatrutide GLP-1/GIP/Glucagon triple Full metabolic axis Weekly SC
AOD 9604 Beta-3 adrenergic Direct lipolysis Daily SC
MOTS-C AMPK activation Mitochondrial fat oxidation 3-5x/week SC
Tesamorelin GHRH analog Visceral fat via GH Daily SC

For research purposes only. Browse our full catalog. Verify purity at COAs.

Related Articles


All products are sold strictly for research purposes only. Not for human consumption.

📦 USA Manufacturing ✅ 99.99% Purity 📦 Free Shipping $150+

Related Articles

0
    0
    Your Cart
    Your cart is emptyReturn to Shop